Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The heart in sickle cell anemia

R H Falk, W B Hood

    Archives of Internal Medicine
    |September 1, 1982
    PubMed
    Summary

    Sickle cell anemia (SCA) patients experience organ damage, but the heart is relatively spared. However, cardiac dysfunction may increase as patients live longer, necessitating a review of current knowledge.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Calcium-Proton Exchange During Algal Calcification.

    The Biological bulletin·2018
    Same author

    Amyloid diseases of the heart: assessment, diagnosis, and referral.

    Heart (British Cardiac Society)·2010
    Same author

    Digitalis for treatment of congestive heart failure in patients in sinus rhythm.

    The Cochrane database of systematic reviews·2004
    Same author

    High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.

    Bone marrow transplantation·2003
    Same author

    Digitalis for treatment of congestive heart failure in patients in sinus rhythm.

    Nursing times·2002
    Same author

    An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.

    Bone marrow transplantation·2001

    Area of Science:

    • Hematology
    • Cardiology
    • Internal Medicine

    Background:

    • Sickle cell anemia (SCA) is a chronic, debilitating genetic blood disorder.
    • SCA causes progressive damage to multiple organ systems.
    • Cardiac abnormalities occur in SCA, but the heart is considered relatively spared compared to other organs.

    Purpose of the Study:

    • To review current knowledge on cardiac involvement in sickle cell anemia.
    • To highlight the impact of increasing patient lifespan on cardiac function in SCA.

    Main Methods:

    • Review of recent noninvasive studies.
    • Review of pathologic studies.
    • Synthesis of existing literature on cardiac manifestations in SCA.

    Main Results:

    • While the heart is relatively spared, abnormalities are present in sickle cell anemia patients.
    • Increasing lifespan in SCA patients may lead to more prominent cardiac dysfunction.
    • New insights into SCA's cardiac effects are emerging from recent research.

    Conclusions:

    • Cardiac involvement in sickle cell anemia is an evolving area of study.
    • Long-term survival in SCA necessitates closer monitoring of cardiac health.
    • Further research is crucial to understand and manage cardiac complications in SCA.

    Related Experiment Videos